Article
The introduction of systematic genomic testing for patients with non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Dec 2012
Cardarella Stephanie, Ortiz Taylor M, Joshi Victoria A, Butaney Mohit, Jackman David M, Kwiatkowski David J, Yeap Beow Y, Jänne Pasi A, Lindeman Neal I, Johnson Bruce E
Abstract excerpt
BACKGROUND: Genomic testing to identify driver mutations that enable targeted therapy is emerging for patients with non-small-cell lung cancer (NSCLC). We report the implementation of systematic prospective genotyping for somatic alterations in BRAF, PIK3CA, HER2, and ALK, in addition to EGFR and KRAS, in NSCLC patients at the Dana-Farber Cancer Institute. METHODS: Patients with NSCLC were prospectively referred...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
